MIMI TYSON: Open Payments
NPI 1952960924 · NORTH BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $255 · 2025 $392
Food & beverage: $365Education: $27
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $189 |
| Supernus Pharmaceuticals, Inc. | 5 | $88 |
| ABBVIE INC. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Lundbeck LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: COBENFY, Qelbree, REXULTI, VRAYLAR, CAPLYTA.
Industry payments across MD — which companies pay providers there.
